פטיר

Country: Israel

Language: Hebrew

Source: Ministry of Health

Buy It Now

Active ingredient:

TERBINAFINE HYDROCHLORIDE

Available from:

RAFA LABORATORIES LTD

ATC code:

D01BA02

Pharmaceutical form:

קרם

Composition:

TERBINAFINE HYDROCHLORIDE 1 %

Administration route:

עורי

Prescription type:

אין צורך במרשם

Manufactured by:

RAFA LABORATORIES LTD, JERUSALEM

Therapeutic group:

TERBINAFINE

Therapeutic area:

TERBINAFINE

Therapeutic indications:

Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g.T.rubrum, T. mentagrophytes, T. verrucosu, T. violaceum), Microsporum canis and Epidemophyton floccosum. Yeast infections of the skin, principally those caused by the genus Candida (e.g. candida albicans). Pityriasis (tinea versicolor due to pityrosporum orbiculare (also known as malassezia furfur).

Authorization date:

2021-05-31

Patient Information leaflet

                                1 ״ )
(
-
1986
:
1%
1%
Terbinafine Hydrochloride
,
6
2
"
." .
.
.
,
.
.
)
(
(
7
)
.
1
.
?
. :
.
2
.
:
•
)
(
(
6
)
.
•
.
.
,
•
12
.
•
.
•
.
•
,
.
,
,
.
.
•
.
, : , , , .
.
:
12
. :
•
,
.
•
.
,
•
.
•
.
2 :
. :
•
(
Cetyl alcohol
)
(
Stearyl alcohol
)
:
(
,
contact dermatitis
.)
•
1%
(
Benzyl alcohol
)
.
3
.
?
.
.
,
12
.
.)
/
(
.
:
•
(
Tinea Pedis
,
,)
-
.
•
/
([
Plantar - type Tinea Pedis
(Moccasin Type
]
-
.
•
(
skin candidiasis
)
-
.
,
•
)
(
-
.
,
,
,
.
.
.
.
.
,
.
,
.
.
. , :
,
,
.
.
.
, ! .
.
?
:
•
.
•
.
•
.
•
.
•
,
.
,
.
. , .
3
4
.
,
.
.
.
,
:
•
•
,
,
•
:
(
10,000
)
:
:
(
1-10
10,000
)
:
:
(
1-10
100
)
,
:
(
1-10
1000
)
,
,
,
,
:
,
(
1-10
10,000
)
,
,
:
(
contact
dermatitis
)
(
10,000
)
:
:
(
1-10
1000
)
,
:
(
1-10
10,000
)
: , ,
.
"
"
)
www.health.gov.il
(
,
"
:
https://sideeffects.health.gov.il/
5
.
?
•
!
/
.
.
•
(
exp. date
.
)
.
•
:
-
25°C
.
6
,
-
.
6
.
:
Isopropyl myristate, cetyl alcohol, sorbitan monostearate, cetyl ester
wax , stearyl alcohol,
polysorbate 60, benzyl alcohol, sodium hydroxide , HCl, purified
water. :
15
30
.
.
4 :
.
.
"
405
,
,
9100301
,
. :
134-66-31200
2023
.
.
,
.
,
26100
6
-I
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet English 03-12-2020
Public Assessment Report Public Assessment Report English 08-10-2020
Patient Information leaflet Patient Information leaflet Arabic 03-12-2020

Search alerts related to this product

View documents history